Four companies that look strong via technical analysis.
Robotics and artificial intelligence are setting the stage for longer lifespans and new investment opportunities.
Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease. Debjit Chattopadhyay of
Company chart and information is provided by TradingView based on 15-minute-delayed data.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
| Website: | www.neogenomics.com |
| Email: | bill.bonello@neogenomics.com |
| Main Phone: | +1 239 768-0600 |
| Address: | 12701 Commonwealth Drive |
| Address 2: | Suite 9 |
| State: | FL |
| City / Town: | Fort Myers |
| Country: | US |
| Postal Code: | 33913 |
| Exchange: | NSC |
| CEO: | Douglas M. VanOort |
| Employees: | 1700 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
Four companies that look strong via technical analysis.
Robotics and artificial intelligence are setting the stage for longer lifespans and new investment opportunities.
Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease. Debjit Chattopadhyay of
Potential. That's what every investor is looking for in a biotech investment. Grant Zeng of Zacks Small-Cap Research zeroes in on three primary factors when he looks at whether a particular
Shares for Sears Holdings Corp. (SHLD) plummeted some 13.4 percent on Friday, after dropping some 12.4 in early trading, a response to the dismal earnings report the company released late the
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
